vs
Side-by-side financial comparison of BayFirst Financial Corp. (BAFN) and KalVista Pharmaceuticals, Inc. (KALV). Click either name above to swap in a different company.
KalVista Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($13.7M vs $10.3M, roughly 1.3× BayFirst Financial Corp.). BayFirst Financial Corp. runs the higher net margin — -55.0% vs -361.4%, a 306.4% gap on every dollar of revenue.
The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.
KalVista Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel oral serine protease inhibitor therapies. Its core pipeline addresses unmet medical needs for rare and inflammatory diseases including hereditary angioedema and diabetic macular edema, with primary target markets in North America and Europe.
BAFN vs KALV — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $10.3M | $13.7M |
| Net Profit | $-5.7M | $-49.5M |
| Gross Margin | — | 91.0% |
| Operating Margin | — | -336.3% |
| Net Margin | -55.0% | -361.4% |
| Revenue YoY | — | — |
| Net Profit YoY | -130.6% | -17.1% |
| EPS (diluted) | $-1.48 | $-0.92 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $10.3M | — | ||
| Q4 25 | $11.2M | — | ||
| Q3 25 | $10.2M | $13.7M | ||
| Q2 25 | $23.1M | — | ||
| Q1 25 | $19.8M | — | ||
| Q4 24 | $32.9M | — | ||
| Q3 24 | $21.7M | $0 | ||
| Q2 24 | $20.8M | — |
| Q1 26 | $-5.7M | — | ||
| Q4 25 | $-2.5M | — | ||
| Q3 25 | $-18.9M | $-49.5M | ||
| Q2 25 | $-1.2M | — | ||
| Q1 25 | $-335.0K | — | ||
| Q4 24 | $9.8M | — | ||
| Q3 24 | $1.1M | $-40.4M | ||
| Q2 24 | $866.0K | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 91.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | -25.3% | — | ||
| Q3 25 | -253.0% | -336.3% | ||
| Q2 25 | -7.1% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.1% | — | ||
| Q2 24 | 5.9% | — |
| Q1 26 | -55.0% | — | ||
| Q4 25 | -22.1% | — | ||
| Q3 25 | -184.7% | -361.4% | ||
| Q2 25 | -5.3% | — | ||
| Q1 25 | -1.7% | — | ||
| Q4 24 | 91.8% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 4.2% | — |
| Q1 26 | $-1.48 | — | ||
| Q4 25 | $-0.71 | — | ||
| Q3 25 | $-4.66 | $-0.92 | ||
| Q2 25 | $-0.39 | — | ||
| Q1 25 | $-0.17 | — | ||
| Q4 24 | $2.21 | — | ||
| Q3 24 | $0.18 | $-0.87 | ||
| Q2 24 | $0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $134.5M | $243.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $81.9M | $17.0M |
| Total Assets | $1.2B | $339.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $134.5M | — | ||
| Q4 25 | $207.0M | — | ||
| Q3 25 | $118.5M | $243.5M | ||
| Q2 25 | $77.3M | — | ||
| Q1 25 | $63.2M | — | ||
| Q4 24 | $77.8M | — | ||
| Q3 24 | $64.4M | $31.8M | ||
| Q2 24 | $60.8M | — |
| Q1 26 | $81.9M | — | ||
| Q4 25 | $87.6M | — | ||
| Q3 25 | $89.7M | $17.0M | ||
| Q2 25 | $108.2M | — | ||
| Q1 25 | $110.1M | — | ||
| Q4 24 | $110.9M | — | ||
| Q3 24 | $102.3M | $172.8M | ||
| Q2 24 | $101.0M | — |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $339.9M | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.2B | $200.2M | ||
| Q2 24 | $1.2B | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BAFN
| Net Interest Income | $9.4M | 91% |
| Noninterest Income | $884.0K | 9% |
KALV
Segment breakdown not available.
